In this episode of the Intelligent Wealth Podcast, the hosts take a deep dive into Wise (formerly TransferWise) – one of the UK’s standout fintech success stories.

Wise processes over £145 billion in cross-border transactions annually, offering faster, cheaper money transfers than traditional banks. But is it really a quality long-term investment?

We cover:
00:00 Introduction to Quality Investing
01:51 Exploring Wise: A Fintech Disruptor
05:23 Wise's Performance and Market Position
10:43 Investment Insights and Mission-Driven Business
16:04 Risks and Criticisms of Wise
26:55 Future Outlook and Conclusion

📊 If you’d like a 1-page Wise company snapshot, click here to download: https://mailchi.mp/minervamoneymanagement/how-to-get-top-10-company-snapshots

🌐 Minerva Money Management – https://minervamoneymanagement.co.uk
🌐 Wise: https://wise.com/

👉 Next Episode Preview: The Smarter Web Company - a United Kingdom-based technology company and web design agency founded in 2009 that specialises in designing and building websites. The company has adopted a unique Bitcoin Treasury Policy by accepting and holding Bitcoin as part of its financial strategy.

Thank you all for listening!

Disclaimer:
The value of investments can rise as well as fall. You may not get back the full amount you invested. The views stated in this podcast are purely personal opinions, not advice. You should always consult a professional for investment advice.
--------------------

Music from #Uppbeat (free for Creators!):
https://uppbeat.io/t/abbynoise/night-...
License code: C4BIIEC6POGUQVDJ

MicroStrategy has become the world’s largest Bitcoin treasury company — raising billions, buying Bitcoin, and transforming from a software business into a crypto giant.

But is this strategy brilliant financial innovation… or a high-risk bubble waiting to burst?

In this episode of the Intelligent Wealth Podcast, Tony, Carl, and Awet debate:
1. MicroStrategy’s 2,400% share price rise in 5 years vs. Bitcoin’s 888%
2. How they raise funds through bonds & equity to keep buying BTC
3. Risks of extreme debt, volatility & exogenous shocks
4. Michael Saylor’s vision, innovation, and cult-like following
5. Is it smarter to own MicroStrategy stock… or just Bitcoin itself?

📌 Links & Mentions:
🧾 Download the Company Snapshot: https://mailchi.mp/minervamoneymanagement/how-to-get-top-10-company-snapshots

🌐 Minerva Money Management – https://minervamoneymanagement.co.uk
🌐 Strategy: https://www.strategy.com/

Next Episode Preview: Wise — a British financial technology company focused on global money transfers

Thank you all for listening!

Disclaimer:
The value of investments can rise as well as fall. You may not get back the full amount you invested. The views stated in this podcast are purely personal opinions, not advice. You should always consult a professional for investment advice.
--------------------

Music from #Uppbeat (free for Creators!):
https://uppbeat.io/t/abbynoise/night-...
License code: C4BIIEC6POGUQVDJ

🚨 Novo Nordisk Stock Down 66% - Is This a Golden Buying Opportunity or a Red Flag?

In this episode of the Intelligent Wealth Podcast, our expert panel dives deep into the recent plunge in Novo Nordisk’s stock price - one of the most dominant pharmaceutical companies globally in the obesity and diabetes drug market.

With insights from Awet, Head of Research, directors Carl Roberts and Tony Byrne at Minerva Money Management, we unpack:

* Why Novo Nordisk's share price crashed
* How competition from Eli Lilly is reshaping the market
* Whether Trump-era drug pricing pressure is here to stay
* The massive $10B investment in US manufacturing
* Forward PE vs. industry average — is Novo now undervalued?
* Why diabetes and obesity drugs are only going to grow in demand
* Is this stock mispriced right now?

With 63% market share in diabetes drugs and strong recurring revenue, can Novo Nordisk weather the storm and come out stronger? Or is the market pricing in long-term trouble?

Timestamps:
0:00 - Introduction
1:30 - Novo Nordisk: Company Background
6:30 - Stock Price Crash Explained
10:00 - Financials & Valuation Metrics
14:00 - Global Diabetes & Obesity Trends
20:00 - Trump, Tariffs & Drug Price Pressure
24:00 - Competitive Moats & R&D Edge
27:00 - Final Verdict: Buy, Hold, or Avoid?

🎧 Listen on Apple: https://podcasts.apple.com/ch/podcast/intelligent-wealth-podcast/id1750755768?l=it

📌 Links & Mentions:
🧾 Download the 1-page Novo Nordisk Company Snapshot: https://mailchi.mp/minervamoneymanagement/how-to-get-top-10-company-snapshots

🌐 Minerva Money Management – https://minervamoneymanagement.co.uk
🌐 Novo Nordisk – https://www.novonordisk.com/

Next Episode Preview: MicroStrategy — Bitcoin treasury play or dangerous bet?

Thank you all for listening!

Disclaimer:
The value of investments can rise as well as fall. You may not get back the full amount you invested. The views stated in this podcast are purely personal opinions, not advice. You should always consult a professional for investment advice.
--------------------

Music from #Uppbeat (free for Creators!):
https://uppbeat.io/t/abbynoise/night-...
License code: C4BIIEC6POGUQVDJ